Does Early Tacrolimus Exposure Affect Long-term Outcome in Patients Treated de Novo with Once-daily Tacrolimus after Liver Transplantation?

被引:0
|
作者
Gastaca, M. [1 ]
Bustamante, J. [1 ]
Valdivieso, A. [1 ]
Ruiz, P. [1 ]
Ventoso, A. [1 ]
Farnandez, J. R. [1 ]
Palomares, I. [1 ]
Prieto, M. [1 ]
Testillano, M. [1 ]
Salvador, P. [1 ]
Senosiain, M. [1 ]
Matarranz, A. [1 ]
Suarez, M. J. [1 ]
Ortiz de Urbina, J. [1 ]
机构
[1] Cruces Univ Hosp, Bilbao, Spain
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P-452
引用
收藏
页码:291 / 292
页数:2
相关论文
共 50 条
  • [21] ONCE-DAILY PROLONGED-RELEASE TACROLIMUS IN DE-NOVO LIVER TRANSPLANTATION: A CASE MATCH ANALYSIS WITH TWICE-DAILY TACROLIMUS FORMULATION
    Lupo, Francesco
    Tandoi, Francesco
    Mazza, Elena
    Catalano, Giorgia
    Nada, Elisabetta
    Patrono, Damiano
    Galasso, Erica
    Mirabella, Stefano
    Cocchis, Donatella
    Romagnoli, Renato
    Salizzoni, Mauro
    TRANSPLANT INTERNATIONAL, 2015, 28 : 724 - 724
  • [22] Pharmacokinetics and Pharmacodynamics of Once-Daily Tacrolimus Compared With Twice-Daily Tacrolimus in the Early Stage After Living Donor Liver Transplantation
    Iwasaki, Mami
    Yano, Ikuko
    Fukatsu, Sachio
    Hashi, Sachiyo
    Yamamoto, Yuki
    Sugimoto, Mitsuhiro
    Fukudo, Masahide
    Masuda, Satohiro
    Nakagawa, Shunsaku
    Yonezawa, Atsushi
    Kaido, Toshimi
    Uemoto, Shinji
    Matsubara, Kazuo
    THERAPEUTIC DRUG MONITORING, 2018, 40 (06) : 675 - 681
  • [23] Intestinal Permeability in Patients Early after Kidney Transplantation Treated with Two Different Formulations of Once-Daily Tacrolimus
    Kolonko, Aureliusz
    Slabiak-Blaz, Natalia
    Pokora, Patrycja
    Piecha, Grzegorz
    Wiecek, Andrzej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [24] Once-Daily Prolonged-Release Tacrolimus in De Novo Liver Transplantation: A Single Center Cohort Study
    Marubashi, Shigeru
    Wada, Hiroshi
    Kobayashi, Shogo
    Eguchi, Hidetoshi
    Tanemura, Masahiro
    Umeshita, Koji
    Doki, Yuichiro
    Mori, Masaki
    Nagano, Hiroaki
    HEPATO-GASTROENTEROLOGY, 2012, 59 (116) : 1184 - 1188
  • [25] Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation
    Glander, Petra
    Waiser, Johannes
    Kasbohm, Silke
    Friedersdorff, Frank
    Peters, Robert
    Rudolph, Birgit
    Wu, Kaiyin
    Budde, Klemens
    Liefeldt, Lutz
    CLINICAL TRANSPLANTATION, 2018, 32 (08)
  • [26] Conversion from Tacrolimus or Ciclosporine twice-daily to Tacrolimus once-daily in adolescents after pediatric liver transplantation
    Weil, T.
    Debray, D.
    Kramer, L.
    Habes, D.
    Taburet, A. -M.
    Furlan, V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 144 - 144
  • [27] Long-Term Follow-Up After Conversion from Twice-Daily Tacrolimus Formulation to Once-Daily Tacrolimus Formulation in Pediatric Kidney Transplantation
    Choi, C.
    Han, A.
    Min, S.
    Min, S. -K.
    Lee, T.
    Jung, I. -M.
    Kim, S.
    Ha, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [28] Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome
    Rodriguez-Peralvarez, Manuel
    Germani, Giacomo
    Papastergiou, Vasilios
    Tsochatzis, Emmanuel
    Thalassinos, Evangelos
    Tu Vinh Luong
    Rolando, Nancy
    Dhillon, Amar Paul
    Patch, David
    O'Beirne, James
    Thorburn, Douglas
    Burroughs, Andrew Kenneth
    JOURNAL OF HEPATOLOGY, 2013, 58 (02) : 262 - 270
  • [29] THE EXTENT OF TACROLIMUS EXPOSURE MAY NOT AFFECT THE RISK OF DE NOVO MALIGNANCY AFTER LIVER TRANSPLANTATION
    Coe, Christopher L.
    Spann, Ashley
    Ajayi, Teminioluwa
    Montgomery, Garren S.
    Shwetar, Mohammed
    Feurer, Irene
    Rega, Scott
    McCoy, Allison
    Alexopoulos, Sophoclis
    Izzy, Manhal
    HEPATOLOGY, 2020, 72 : 849A - 850A
  • [30] Conversion from tacrolimus twice-daily (Prograf) to tacrolimus once-daily (Advagraf) in adolescents after pediatric liver transplantation
    Weil, T.
    Debray, D.
    Kramer, L.
    Habes, D.
    Taburet, A. M.
    Furlan, V
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 536 - 537